Stanford Scientists Spot Eye Proteins That Clock Age and Disease
Researchers at Stanford University have cracked the code to mapping proteins inside the eye using tiny fluid drops grabbed during surgery. By analysing nearly 6,000 proteins, they’ve built a “proteomic clock” that can predict your age just from your eye’s protein profile. The study, published in Cell, also reveals how eye diseases like diabetic retinopathy and uveitis speed up aging in specific eye cells.
Protein Clues Could Spot Parkinson’s Early
In a shocking twist, the team discovered proteins linked to Parkinson’s disease in eye fluid. This opens the door for earlier diagnosis and better tracking of Parkinson’s—something current tests struggle with.
“Being able to watch diseases in real-time inside the eye is truly exciting,” said senior author Vinit Mahajan, a Stanford ophthalmology professor. “Connecting what we see anatomically with molecular changes is key to better treatments.”
Why the Eye? And How Did They Do It?
The eye’s a tough organ to sample because, like the brain, it doesn’t regenerate. Taking tissue could cause permanent damage, so liquid biopsies using fluid near affected cells are preferred. But until now, tech couldn’t measure so many proteins in such tiny fluid samples or pinpoint their cell origins.
Mahajan’s team smashed these limits with a high-res method, identifying an incredible 5,953 proteins—ten times more than previous studies. Their software tool, TEMPO, traced each protein back to the specific cell type.
AI Model Reveals Aging’s Dark Side in Eye Diseases
Using AI and machine learning, the researchers created a model to predict the molecular age of healthy eyes. They found significant aging linked to disease. For diabetic retinopathy, aging sped up drastically as the disease worsened. Some sufferers’ eyes appeared 30 years older on a molecular level, even before symptoms showed—and this aging stuck around post-treatment.
These findings suggest aging may target certain organs or cell types, reshaping how we approach precision medicine. Targeted anti-aging drugs could be the future of preventative care.
What’s Next?
The team plans to widen their research to more patients and eye diseases. They also want to apply their liquid biopsy method to other hard-to-sample organs like the brain, joints, and kidneys. This breakthrough could revolutionise ophthalmology and deepen our grasp of diseases far beyond the eye.
